Generation of IBMS-iPSC-015, -016, -017 human induced pluripotent stem cells (IBMSi013-A, IBMSi014-A, and IBMSi015-A) derived from patients with atrial fibrillation

Generation of IBMS-iPSC-015, -016, -017 human induced pluripotent stem cells (IBMSi013-A, IBMSi014-A, and IBMSi015-A) derived from patients with atrial fibrillation

Atrial fibrillation is the most common heart disease in the world, with around 35 million patients in 2020. Here we reported the generation of IBMS-iPSC-015-06, IBMS-iPSC-016-06, and IBMS-iPSC-017-02 as human induced pluripotent stem cell (iPSC) lines from patients’ peripheral blood mononuclear cell...

Full description

Bibliographic Details
Main Authors: Yueh-Ting Chiu, Ming-Heng Tsai, Darien Zhing-Herr Chan, Hui-Wen Ko, Huai-En Lu, Chi-Ying F. Huang, Yenn-Jiang Lin, Shih-Lin Chang, Li-Wei Lo, Ching-Ying Huang, Yu-Feng Hu, Patrick C.H. Hsieh, Shih-Ann Chen
Format: Article
Language:English
Published: Elsevier 2021-07-01
Series:Stem Cell Research
Online Access:http://www.sciencedirect.com/science/article/pii/S1873506121002658
id doaj-1b668b07523442b7bfd6770f14687869
record_format Article
spelling doaj-1b668b07523442b7bfd6770f146878692021-07-09T04:42:40ZengElsevierStem Cell Research1873-50612021-07-0154102419Generation of IBMS-iPSC-015, -016, -017 human induced pluripotent stem cells (IBMSi013-A, IBMSi014-A, and IBMSi015-A) derived from patients with atrial fibrillationYueh-Ting Chiu0Ming-Heng Tsai1Darien Zhing-Herr Chan2Hui-Wen Ko3Huai-En Lu4Chi-Ying F. Huang5Yenn-Jiang Lin6Shih-Lin Chang7Li-Wei Lo8Ching-Ying Huang9Yu-Feng Hu10Patrick C.H. Hsieh11Shih-Ann Chen12Institute of Biomedical Sciences, Academia Sinica, Taipei, TaiwanInstitute of Biomedical Sciences, Academia Sinica, Taipei, TaiwanInstitute of Biomedical Sciences, Academia Sinica, Taipei, TaiwanFood Industry Research and Development Institute, Hsinchu, TaiwanFood Industry Research and Development Institute, Hsinchu, TaiwanInstitute of Biopharmaceutical Sciences, National Yang Ming University, Taipei, TaiwanFaculty of Medicine, School of Medicine, National Yang-Ming University, Taipei, Taiwan; Heart Rhythm Center, Division of Cardiology, Department of Medicine, Taipei Veterans General Hospital, Taipei, TaiwanFaculty of Medicine, School of Medicine, National Yang-Ming University, Taipei, Taiwan; Heart Rhythm Center, Division of Cardiology, Department of Medicine, Taipei Veterans General Hospital, Taipei, TaiwanFaculty of Medicine, School of Medicine, National Yang-Ming University, Taipei, Taiwan; Heart Rhythm Center, Division of Cardiology, Department of Medicine, Taipei Veterans General Hospital, Taipei, TaiwanInstitute of Biomedical Sciences, Academia Sinica, Taipei, TaiwanInstitute of Biomedical Sciences, Academia Sinica, Taipei, Taiwan; Faculty of Medicine, School of Medicine, National Yang-Ming University, Taipei, Taiwan; Heart Rhythm Center, Division of Cardiology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan; Corresponding authors.Institute of Biomedical Sciences, Academia Sinica, Taipei, Taiwan; Corresponding authors.Faculty of Medicine, School of Medicine, National Yang-Ming University, Taipei, Taiwan; Heart Rhythm Center, Division of Cardiology, Department of Medicine, Taipei Veterans General Hospital, Taipei, TaiwanAtrial fibrillation is the most common heart disease in the world, with around 35 million patients in 2020. Here we reported the generation of IBMS-iPSC-015-06, IBMS-iPSC-016-06, and IBMS-iPSC-017-02 as human induced pluripotent stem cell (iPSC) lines from patients’ peripheral blood mononuclear cells (PBMCs) with atrial fibrillation. The cell lines expressed properties of pluripotent stem cells, including pluripotent markers and the ability to differentiate into three germ layers. These cell lines served as suitable models for studying alternative therapies of atrial fibrillation.http://www.sciencedirect.com/science/article/pii/S1873506121002658
collection DOAJ
language English
format Article
sources DOAJ
author Yueh-Ting Chiu
Ming-Heng Tsai
Darien Zhing-Herr Chan
Hui-Wen Ko
Huai-En Lu
Chi-Ying F. Huang
Yenn-Jiang Lin
Shih-Lin Chang
Li-Wei Lo
Ching-Ying Huang
Yu-Feng Hu
Patrick C.H. Hsieh
Shih-Ann Chen
spellingShingle Yueh-Ting Chiu
Ming-Heng Tsai
Darien Zhing-Herr Chan
Hui-Wen Ko
Huai-En Lu
Chi-Ying F. Huang
Yenn-Jiang Lin
Shih-Lin Chang
Li-Wei Lo
Ching-Ying Huang
Yu-Feng Hu
Patrick C.H. Hsieh
Shih-Ann Chen
Generation of IBMS-iPSC-015, -016, -017 human induced pluripotent stem cells (IBMSi013-A, IBMSi014-A, and IBMSi015-A) derived from patients with atrial fibrillation
Stem Cell Research
author_facet Yueh-Ting Chiu
Ming-Heng Tsai
Darien Zhing-Herr Chan
Hui-Wen Ko
Huai-En Lu
Chi-Ying F. Huang
Yenn-Jiang Lin
Shih-Lin Chang
Li-Wei Lo
Ching-Ying Huang
Yu-Feng Hu
Patrick C.H. Hsieh
Shih-Ann Chen
author_sort Yueh-Ting Chiu
title Generation of IBMS-iPSC-015, -016, -017 human induced pluripotent stem cells (IBMSi013-A, IBMSi014-A, and IBMSi015-A) derived from patients with atrial fibrillation
title_short Generation of IBMS-iPSC-015, -016, -017 human induced pluripotent stem cells (IBMSi013-A, IBMSi014-A, and IBMSi015-A) derived from patients with atrial fibrillation
title_full Generation of IBMS-iPSC-015, -016, -017 human induced pluripotent stem cells (IBMSi013-A, IBMSi014-A, and IBMSi015-A) derived from patients with atrial fibrillation
title_fullStr Generation of IBMS-iPSC-015, -016, -017 human induced pluripotent stem cells (IBMSi013-A, IBMSi014-A, and IBMSi015-A) derived from patients with atrial fibrillation
title_full_unstemmed Generation of IBMS-iPSC-015, -016, -017 human induced pluripotent stem cells (IBMSi013-A, IBMSi014-A, and IBMSi015-A) derived from patients with atrial fibrillation
title_sort generation of ibms-ipsc-015, -016, -017 human induced pluripotent stem cells (ibmsi013-a, ibmsi014-a, and ibmsi015-a) derived from patients with atrial fibrillation
publisher Elsevier
series Stem Cell Research
issn 1873-5061
publishDate 2021-07-01
description Atrial fibrillation is the most common heart disease in the world, with around 35 million patients in 2020. Here we reported the generation of IBMS-iPSC-015-06, IBMS-iPSC-016-06, and IBMS-iPSC-017-02 as human induced pluripotent stem cell (iPSC) lines from patients’ peripheral blood mononuclear cells (PBMCs) with atrial fibrillation. The cell lines expressed properties of pluripotent stem cells, including pluripotent markers and the ability to differentiate into three germ layers. These cell lines served as suitable models for studying alternative therapies of atrial fibrillation.
url http://www.sciencedirect.com/science/article/pii/S1873506121002658
work_keys_str_mv AT yuehtingchiu generationofibmsipsc015016017humaninducedpluripotentstemcellsibmsi013aibmsi014aandibmsi015aderivedfrompatientswithatrialfibrillation
AT minghengtsai generationofibmsipsc015016017humaninducedpluripotentstemcellsibmsi013aibmsi014aandibmsi015aderivedfrompatientswithatrialfibrillation
AT darienzhingherrchan generationofibmsipsc015016017humaninducedpluripotentstemcellsibmsi013aibmsi014aandibmsi015aderivedfrompatientswithatrialfibrillation
AT huiwenko generationofibmsipsc015016017humaninducedpluripotentstemcellsibmsi013aibmsi014aandibmsi015aderivedfrompatientswithatrialfibrillation
AT huaienlu generationofibmsipsc015016017humaninducedpluripotentstemcellsibmsi013aibmsi014aandibmsi015aderivedfrompatientswithatrialfibrillation
AT chiyingfhuang generationofibmsipsc015016017humaninducedpluripotentstemcellsibmsi013aibmsi014aandibmsi015aderivedfrompatientswithatrialfibrillation
AT yennjianglin generationofibmsipsc015016017humaninducedpluripotentstemcellsibmsi013aibmsi014aandibmsi015aderivedfrompatientswithatrialfibrillation
AT shihlinchang generationofibmsipsc015016017humaninducedpluripotentstemcellsibmsi013aibmsi014aandibmsi015aderivedfrompatientswithatrialfibrillation
AT liweilo generationofibmsipsc015016017humaninducedpluripotentstemcellsibmsi013aibmsi014aandibmsi015aderivedfrompatientswithatrialfibrillation
AT chingyinghuang generationofibmsipsc015016017humaninducedpluripotentstemcellsibmsi013aibmsi014aandibmsi015aderivedfrompatientswithatrialfibrillation
AT yufenghu generationofibmsipsc015016017humaninducedpluripotentstemcellsibmsi013aibmsi014aandibmsi015aderivedfrompatientswithatrialfibrillation
AT patrickchhsieh generationofibmsipsc015016017humaninducedpluripotentstemcellsibmsi013aibmsi014aandibmsi015aderivedfrompatientswithatrialfibrillation
AT shihannchen generationofibmsipsc015016017humaninducedpluripotentstemcellsibmsi013aibmsi014aandibmsi015aderivedfrompatientswithatrialfibrillation
_version_ 1721312114813960192

Similar Items